I asked ChatGPT for 3 FTSE 100 picks for a Stocks and Shares ISA. Here’s what it said

Thinking of starting a new Stocks and Shares ISA? It’s worth seeking a range of opinions, but be sure to check them all carefully, especially AI.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ISA Individual Savings Account

Image source: Getty Images

Today’s artificial intelligence (AI) chatbots can give us some starting ideas for a Stocks and Shares ISA. But they’re only that — just starting ideas. I’ve had some hallucinated nonsense from them sometimes.

I’m always careful to ask for sources and I check them directly — although some of the sources didn’t even mention the suggested stocks this time. But I like the look of these three, even though it took some some careful probing.

Buy big oil?

Despite the on/off global political tussle between hydrocarbons and renewable energy, ISA providers are still seeing Shell (LSE: SHEL) as a popular choice with Stocks and Shares ISA investors.

Shell looks to have better defensive qualities than some, partly in the strength of its balance sheet. For the first half this year, the company reported $11.9 billion cash flow, “primarily driven by Adjusted EBITDA“.

The company’s achieved some impressive cost reductions, completed $3.5bn in share buybacks in the half, and has a 4.1% forecast dividend yield.

The robot brain did point out the long-term risk of future restrictions on fossil fuel use, as regulations could well sway back in favour of alternative energy sources. In fact, I think they eventually have to. But I still see potential for solid dividends for many years to come.

Pharma too

AstraZeneca‘s (LSE: AZN) another popular choice, especially now that earnings are catching up with the lofty valuations of a few years ago.

As recently as 2022, AstraZeneca ended the year on a trailing price-to-earnings (P/E) ratio up in the 60s. Today, we’re looking at a forecast multiple of 22, dropping under 17 by 2027.

It’s all been made possible by the company’s strong drug development pipeline. And we’re regularly hearing news of the latest drug trials and approvals.

Patent expiries are always a long-term risk in this business. And it can only take one expensive drug development failure to hit a company’s bottom line — and the share price.

But analysts point out that health-related stocks tend to have good defensive traits in times of stock market troubles.

Banking’s everything

Behind every successful company in every sector lies one essential service — banking. And that’s helping keep HSBC Holdings (LSE: HSBA) among today’s Stocks and Shares ISA favourites.

Geopolitical factors might make shareholders a bit nervous. And the apparent US obsession over Chinese trade is unlikely to help companies doing most of their business in that part of the world.

But there are two sides to that. Which nation is most likely to be the powerhouse of economic growth in the coming decades? Though some might think we can legislate otherwise, my eyes are still keenly focused eastwards on that one.

I’m maybe a bit concerned by the stock valuation getting up there a bit. A P/E of 11 is at the top end of the FTSE 100 banks. But earnings forecasts do have it dropping in the next couple of years.

Good start?

I see all three of these as good stocks to consider for an ISA, especially for someone starting out. They’re in three very different sectors, which helps balance risks. But for the next steps, I reckon further diversification is needed.

HSBC Holdings is an advertising partner of Motley Fool Money. Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Could this cheap FTSE 100 stock be the next Rolls-Royce?

Paul Summers casts his eye over a battered-but-high-quality FTSE 100 stock. Is this the next top-tier company to stage a…

Read more »

ISA Individual Savings Account
Investing Articles

Hesitant over a Stocks and Shares ISA? Here’s a way to deal with scary markets

Volatile stock markets are scaring potential investors away from getting started with their first Stocks and Shares ISA in 2026.

Read more »

This way, That way, The other way - pointing in different directions
Market Movers

Standard Life’s announced a £2bn deal but its share price is largely unchanged. Why?

James Beard considers why the Standard Life share price didn’t take off today (15 April) after the group announced it…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »